(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/JeFr8oRO5v.png?ph=true&h=300&w=458 "(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | JeFr8oRO5v |
|---|---|
| InChI | InChI=1S/C18H27NO2/c1-5-16(20)15-12-18(15,17(21)19(6-2)7-3)14-10-8-9-13(4)11-14/h8-11,15-16,20H,5-7,12H2,1-4H3/t15-,16-,18+/m0/s1 |
| InChIKey | FJXXXAIXWLXASU-XYJFISCASA-N |
| Mol Weight | 289.42 g/mol |
| Molecular Formula | C18H27NO2 |
| Exact Mass | 289.204179 g/mol |
| Enantiomer InChIKey | FJXXXAIXWLXASU-NUJGCVRESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOHEXYLENECYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DI-ISOBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(2-NAPHTHYL)-2-FORMYL-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
DIETHYL(2-HYDROXYETHYL)METHYLAMMONIUM IODIDE, 4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINEPROPIONATE
4-[3-(4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINYL)PROPIONYL]MORPHOLINE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |